VRK2 and pancreatic neoplasm: In conclusion, the findings of this study suggest that the expression of VRK2 is upregulated in pancreatic cancer and that VRK2 activates the NF-κB signaling pathway by phosphorylating IKKβ, thereby promoting the progression of pancreatic cancer.